Teva Pharmaceutical Industries, Eli Lilly, Pfizer, Johnson & Johnson, Purdue Pharma, Endo Pharmaceuticals, Forest Laboratories, GlaxoSmithKline, F. Hoffmann-La Roche, Baxter International and Valeant Pharmaceuticals International are some of the major players in the global postoperative pain management market.
Postoperative pain management decreases the likelihood of pulmonary, cardiac and neuropathic pain complications and aids in minimizing the cost of hospital stay. An increasing number of surgeries and greater demand for pain management treatment drives this market’s growth.
More articles on anesthesia:
FDA declares kratom unsafe ‘opioid,’ supporters of kratom disagree: 6 insights
FDA releases revised opioid blueprint to educate prescribers, mitigate opioid crisis: 4 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
